Saturday, July 11, 2026

biotech

Hansa Biopharma

Hansa Biopharma clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Lund, SE HQ
2007 Founded
136 Employees
EMA registrant Type
Company details
Intelligence · Clinical Programs

Hansa Biopharma projects

1 ClinicalTrials.gov programs sponsored by Hansa Biopharma.

Hansa Biopharma has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Idefirix 11 mg powder for concentrate for solution for infusion

    Hansa Biopharma AB

    End stage chronic kidney disease (CKD) patients who are highly sensitised and on the kidney transplant list awaiting a kidney transplant

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Hansa Biopharma have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.